ANRIL long non-coding RNA, human

Known as: CDKN2B-AS long non-coding RNA, human, CDKN2B antisense RNA, human, antisense noncoding RNA in the INK4 locus, human 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
0120112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Platinum-based chemotherapy is the standard first-line treatment for most lung cancer patients. However, the toxicity induced by… (More)
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
2017
2017
OBJECTIVE This study aimed to explore the effects of lncRNA ANRIL on vascular endothelial growth factor (VEGF) and angiogenesis… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Some studies investigated the association of antisense non-coding RNA in the INK4 locus (ANRIL) rs2383207 polymorphism with… (More)
Is this relevant?
2011
2011
OBJECTIVE The pathophysiology underlying the chromosome (Chr) 9p21 locus of atherosclerosis susceptibility is presently unknown… (More)
Is this relevant?